August 25, 2026 07:03 am (IST)
Follow us:
Aurobindo Pharma receives USFDA approval for drug related to moderate dementia
Hyderabad/Mumbai, Mar 29 (IBNS) Aurobindo Pharma Limited, which manufactures generic pharmaceuticals and active pharmaceutical ingredients, announced on Tuesday that the company has received the final approval from the US Food & Drug Administration (USFDA) to manufacture and market Rivastigmine Tartrate Capsules USP, 1.5 mg, 3 mg, 4.5 mg and 6 mg.
This product is expected to be launched in the first quarter of fiscal year 2016-17.
The approved ANDA is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Exelon Capsules, 1.5 mg, 3 mg, 4.5 mg and 6 mg, of Novartis Pharmaceuticals Corporation, said the company.
Naproxen Sodium Tablets is used in the treatment of mild moderate dementia of the Alzheimer's and Parkinson's disease.
The approved product has an estimated market size of US$ 26.7 million for the twelve months ending January 2016 according to IMS.
This is the 67th ANDA (including 14 tentative approvals) to be approved out of Unit VII formulation facility in Hyderabad, India for manufacturing oral non-antibiotic products.
Aurobindo now has a total of 246 ANDA approvals (211 Final approvals including 10 from Aurolife Pharma LLC and 35 tentative approvals) from USFDA.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Tata Power Renewables marks a major milestone with the commissioning of 190.5 MW FDRE project in Rajasthan. All details inside
Mon, Aug 24 2026
Samsung's big AI push in India: New Pune facility to power next-gen data centre cooling
Mon, Aug 24 2026
Best Indicators For Futures Trading
Mon, Aug 24 2026
China orders massive EV recall: Nearly 3 million Teslas among 4.3 million vehicles affected
Mon, Aug 24 2026
Yes Bank launches ‘YES Essence’ for women. How can you avail it?
Fri, Aug 21 2026
Aditya Birla Capital enters gold loans: What consumers should know
Fri, Aug 21 2026